MSC-based therapies in solid organ transplantation

被引:11
作者
Benseler, V. [1 ]
Obermajer, N. [1 ]
Johnson, C. L. [1 ]
Soeder, Y. [1 ]
Dahlke, M. D. [1 ]
Popp, F. C. [1 ]
机构
[1] Univ Regensburg, Dept Surg, D-93053 Regensburg, Germany
关键词
Mesenchymal stem cells; Tolerance induction; Solid organ transplantation; Stem cells; Liver transplantation; MESENCHYMAL STEM-CELLS; ADULT PROGENITOR CELLS; MARROW STROMAL CELLS; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; PHASE-I; INFUSION; IMMUNE; IMMUNOSUPPRESSION; INDUCTION;
D O I
10.1007/s12072-013-9509-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Immunomodulatory cell therapy as a complement to standard pharmacotherapy represents a novel approach to solid organ allograft acceptance. This methodology may allow for a reduced dose of immunosuppressive drug to be administered and thus attenuate the severe side effects associated with long-term immunosuppression such as drug-related impairment of renal function, increased risk from opportunistic infections and malignancies. Mesenchymal stem cells (MSCs) have been shown to possess both immune modulatory and regenerative properties in vitro and in preclinical models. Encouraging results have been reported from studies examining the safety and efficacy of MSCs as a treatment for acute graft-versus-host disease. MSCs represent a promising candidate cell therapy to supplement immunosuppression in recipients of solid organs, and initial reports on the clinical use of MSCs in kidney transplantation have been recently published (Tan et al. in J Am Med Assoc 307:1169-1177, 2012; Reinders et al. in Stem Cells Transl Med 2:107-111, 2013; Perico et al. in Transpl Int 26:867-878, 2013; Perico et al. in Clin J Am Soc Nephrol 6:412-422, 2011). An area of even greater interest might be the application of MSCs in clinical liver transplantation as graft survival is closely associated with overall patient survival. Here, we present preclinical findings and discuss their possible impact on clinical liver transplantation. Then we discuss clinical studies designed to investigate how MSCs may be distributed and act in solid organ transplantation.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 50 条
  • [31] High risk of osteoporosis and fracture following solid organ transplantation: a population-based study
    Chen, Hsin
    Lai, Yung-Rung
    Yang, Yih
    Gau, Shuo-Yan
    Huang, Cheng-Yang
    Tsai, Tung-Han
    Huang, Kuang-Hua
    Lee, Chien-Ying
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [32] The issue of heterogeneity of MSC-based advanced therapy medicinal products-a review
    Cesnik, Ana Bajc
    Svajger, Urban
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [33] How to introduce MSC-based therapy for the developing lung safely into clinical care?
    Ruediger, Mario
    Kirpalani, Haresh
    Steinhorn, Robin
    Davis, Jonathan M.
    Thebaud, Bernard
    PEDIATRIC RESEARCH, 2020, 88 (03) : 365 - 368
  • [34] Metabolic Consequences of Solid Organ Transplantation
    Bhat, Mamatha
    Usmani, Shirine E.
    Azhie, Amirhossein
    Woo, Minna
    ENDOCRINE REVIEWS, 2021, 42 (02) : 171 - 197
  • [35] JAK Inhibitors in Solid Organ Transplantation
    Assadiasl, Sara
    Mojtahedi, Hanieh
    Nicknam, Mohammad Hossein
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (12) : 1330 - 1343
  • [36] Osteoporosis after solid organ transplantation
    Kulak, C. A. M.
    Cochenski Borba, V. Z.
    Kulak, J., Jr.
    Custodio, M. Ribeiro
    MINERVA ENDOCRINOLOGICA, 2012, 32 (03) : 221 - 231
  • [37] Mesenchymal stem cells: application for solid-organ transplantation
    Roemeling-van Rhijn, Marieke
    Weimar, Willem
    Hoogduijn, Martin J.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2012, 17 (01) : 55 - 62
  • [38] Solid Organ Transplantation
    Bal, Susan
    Landau, Heather J.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (06) : 1161 - +
  • [39] Cellular Therapies in Solid Organ Allotransplantation: Promise and Pitfalls
    Shaw, Brian, I
    Ord, Jeffrey R.
    Nobuhara, Chloe
    Luo, Xunrong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [40] MSC-Based Cell Therapy in Neurological Diseases: A Concise Review of the Literature in Pre-Clinical and Clinical Research
    Zhang, Xiaorui
    Kuang, Qihong
    Xu, Jianguang
    Lin, Qing
    Chi, Haoming
    Yu, Daojin
    BIOMOLECULES, 2024, 14 (05)